Effect of 5-lipoxygenase-activating protein inhibiton on coronary atherosclerosis progression in patients with recent acute coronary syndrome: the PASSIVATE randomised clinical trial
1 September 2025 (14:22 - 14:41)
Organised by: 
Abstract
Slides
About the speaker
National University of Singapore, Singapore (Singapore)
2 More presentations in this session
Professor L. Badimon (Barcelona, ES)
Access the full session
The Event
ESC Congress 2025
1 September 2025
14:22 CET
